Ares Financial Consulting, LLC Charles River Laboratories International, Inc. Transaction History
Ares Financial Consulting, LLC
- $105 Billion
- Q4 2025
A detailed history of Ares Financial Consulting, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ares Financial Consulting, LLC holds 3 shares of CRL stock, worth $503. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3Holding current value
$503% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
659Shares Held
51.5MCall Options Held
194KPut Options Held
174K-
Vanguard Group Inc Valley Forge, PA5.89MShares$988 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$854 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.19MShares$535 Million0.09% of portfolio
-
Allspring Global Investments Holdings, LLC2MShares$335 Million0.62% of portfolio
-
State Street Corp Boston, MA1.83MShares$307 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.54B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...